Kantonsspital Aarau

Futó vizsgálatok

• Toboroz

  Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

  NCT07020065· 2. fázis· Forrás

• Toboroz

  Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial

  NCT07263438· 2. fázis· Forrás

• Toboroz

  Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)

  NCT06835049· 2. fázis· Forrás

• Toboroz

  A Space-expanding Shield in Decompressive Hemicraniectomy for Stroke

  NCT06638385· Forrás

• Toboroz

  Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

  NCT07617610· Forrás

• Toboroz

  Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

  NCT05815927· 3. fázis· Forrás

• Toboroz

  Skin Cancer and Hyperthermia and Radiotherapy

  NCT06384053· Forrás

• Toboroz

  Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

  NCT06556446· Forrás

• Toboroz

  Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  NCT05946213· 3. fázis· Forrás

• Toboroz

  Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

  NCT06357754· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Forrás

• Fut, nem toboroz

  MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC

  NCT06095271· Forrás

• Fut, nem toboroz

  Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

  NCT05050162· 2/3. fázis· Forrás

• Fut, nem toboroz

  Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.

  NCT04604067· 2. fázis· Forrás

• Fut, nem toboroz

  Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

  NCT04472949· 2. fázis· Forrás

• Fut, nem toboroz

  Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

  NCT04608318· 3. fázis· Forrás

• Fut, nem toboroz

  Emergency Department Triage of Patients With Acute Chest Pain Based on the ESC 0/1-hour Algorithm (PRESC1SE-MI)

  NCT05649384· Forrás

• Toboroz

  Abbott Vascular Medical Device Registry

  NCT04573660· Forrás

• Toboroz

  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  NCT04625907· 1/2. fázis· Forrás

• Toboroz

  Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions

  NCT04449523· Forrás

• Fut, nem toboroz

  Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

  NCT04245514· 2. fázis· Forrás

• Toboroz

  Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

  NCT05017142· Forrás

• Toboroz

  International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

  NCT04043494· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

  NCT04023526· 2. fázis· Forrás

• Toboroz

  The SwissPrEPared Study

  NCT03893188· Forrás

• Fut, nem toboroz

  1st Line Durvalumab in PS 2 NSCLC Patients

  NCT03620669· 2. fázis· Forrás

• Toboroz

  Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  NCT03678025· 3. fázis· Forrás

• Toboroz

  Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

  NCT03643276· 3. fázis· Forrás

• Fut, nem toboroz

  Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

  NCT03367702· 3. fázis· Forrás

• Fut, nem toboroz

  International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

  NCT02724163· 3. fázis· Forrás

• Meghívásos bevonás

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Forrás

• Fut, nem toboroz

  Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

  NCT01368588· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok4 toboroz
• Prosztatarák2 toboroz
• Stroke (szélütés)2 toboroz
• Szarkóma2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Fej-nyaki daganatok1 toboroz
• Glioblasztóma1 toboroz
• HIV-fertőzés1 toboroz
• Koszorúér-betegség1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Melanóma1 toboroz
• Mielóma multiplex1 toboroz
• Neuromyelitis optica (NMOSD)1 toboroz
• Rheumatoid arthritis1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Tüdőrák1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Toboroz

  A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  NCT05920356· 3. fázis· Forrás

• Lezárult

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· 3. fázis· Forrás

• Leállították

  Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)

  NCT04908956· 2. fázis· Forrás

• Lezárult

  SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

  NCT04480372· 2. fázis· Forrás

• Lezárult

  A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

  NCT04760990· Forrás

• Lezárult

  A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

  NCT04619797· 2/3. fázis· Forrás

• Lezárult

  BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

  NCT03762018· 3. fázis· Forrás

• Leállították

  Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

  NCT03708003· 2. fázis· Forrás

• Lezárult

  CERENOVUS Neurothrombectomy Devices Registry

  NCT03685578· Forrás

• Lezárult

  Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

  NCT03297593· 2. fázis· Forrás

• Lezárult

  Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

  NCT03274687· 3. fázis· Forrás

• Lezárult

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· 3. fázis· Forrás

• Lezárult

  Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

  NCT02572843· 2. fázis· Forrás

• Lezárult

  Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

  NCT01272050· 3. fázis· Forrás

• Leállították

  SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

  NCT01039922· Forrás